Zimmer Biomet Holdings revenue and financials

ZBH · NYSE · USD

$89.68Change from previous close: −2.06%Absolute change: −$1.89

Close · October 6, 2026

In the fiscal year ended December 2025, Zimmer Biomet Holdings reported revenue of $8.23B (+7.20% year over year). Net income was $705.1M, a net margin of 8.6%.

Annual revenue · 2025: $8.23B
  1. $7.67B2016
  2. $7.8B2017
  3. $7.93B2018
  4. $7.98B2019
  5. $6.13B2020
  6. $6.83B2021
  7. $6.94B2022
  8. $7.39B2023
  9. $7.68B2024
  10. $8.23B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+7.20%
2025 vs 2024
Net income growth
−21.98%
2025 vs 2024
Net margin
8.6%
2024: 11.8%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Cash flow · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Operating cash flow448359517419378383506396369228588338
Depreciation and amortization271270284284272254264251243239241241
Capital expenditure-140-114-149-141-131-104-103-85.7-118-137-142-149
Investing cash flow-191-159-322-163-1,384-106-291-155-247-195-221-166
Financing cash flow-271-369-897484164575-241-102-91.9-50.1-251-196
Dividends paid-46.5-46.9-47.5-47.5-47.5-47.8-48.0-49.2-49.4-49.4-50.2-50.1
Share repurchases-251-250-2500.0-7.2-230-72.2-596-85.9-114-410—
Debt issued30.00.00.05242201,74873658545.070.0500-145
Debt repaid0.00.0-6000.00.0-863-850-50.0——-305-20.0
Effect of exchange rates0.01.10.8-3.414.67.0-18.110.0-3.3-5.77.4-3.6
Net change in cash-14.2-168-701736-828859-43.614927.2-22.8124-27.6
Free cash flow30824636827824827940331025290.9447189
Levered free cash flow243110466208192437284332217177427203